Lean Fatty Liver Disease

All six indicators identified fewer than half of patients in the normal BMI group. Lean hepatic steatosis is often underdiagnosed. Lean hepatic steatosis is associated with higher mortality and faster fibrosis progression than disease in overweight patients. Current guidelines do not recommend routine NAFLD screening in lean populations.